IL161573A0 - [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS - Google Patents
[1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTSInfo
- Publication number
- IL161573A0 IL161573A0 IL16157302A IL16157302A IL161573A0 IL 161573 A0 IL161573 A0 IL 161573A0 IL 16157302 A IL16157302 A IL 16157302A IL 16157302 A IL16157302 A IL 16157302A IL 161573 A0 IL161573 A0 IL 161573A0
- Authority
- IL
- Israel
- Prior art keywords
- adenosine
- receptor antagonists
- triazole
- bicyclic
- triazole bicyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33438501P | 2001-11-30 | 2001-11-30 | |
PCT/US2002/037915 WO2003048163A1 (en) | 2001-11-30 | 2002-11-26 | [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS |
Publications (1)
Publication Number | Publication Date |
---|---|
IL161573A0 true IL161573A0 (en) | 2004-09-27 |
Family
ID=23306955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16157302A IL161573A0 (en) | 2001-11-30 | 2002-11-26 | [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS |
Country Status (19)
Country | Link |
---|---|
US (2) | US6875772B2 (hu) |
EP (1) | EP1453836B1 (hu) |
JP (2) | JP4429724B2 (hu) |
KR (1) | KR20050044600A (hu) |
CN (1) | CN1688581A (hu) |
AR (1) | AR037681A1 (hu) |
AT (1) | ATE358130T1 (hu) |
AU (1) | AU2002352933A1 (hu) |
CA (1) | CA2468658C (hu) |
DE (1) | DE60219196T2 (hu) |
ES (1) | ES2283625T3 (hu) |
HK (1) | HK1064097A1 (hu) |
HU (1) | HUP0402324A3 (hu) |
IL (1) | IL161573A0 (hu) |
MX (1) | MXPA04005158A (hu) |
PE (1) | PE20030653A1 (hu) |
TW (1) | TW200300689A (hu) |
WO (1) | WO2003048163A1 (hu) |
ZA (1) | ZA200404168B (hu) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0402324A3 (en) * | 2001-11-30 | 2008-09-29 | Schering Corp | [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine derivatives as adenosine a2a receptor antagonists and pharmaceutical compositions containing them |
PE20030739A1 (es) | 2001-11-30 | 2003-08-28 | Schering Corp | Antagonistas del receptor de adenosina a2a |
AU2003220110B2 (en) * | 2002-03-12 | 2009-04-09 | Wyeth | Process for making chiral 1,4-disubstituted piperazines |
US20060058320A1 (en) * | 2002-09-24 | 2006-03-16 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4] Triazolo[1,5-c]pyrimidine derivatives |
ATE490775T1 (de) | 2002-12-19 | 2010-12-15 | Schering Corp | Verwendung von a2a rezeptor-antagonisten zur behandlung des extrapyramidalen syndroms |
US7834014B2 (en) | 2003-04-09 | 2010-11-16 | Biogen Idec Ma Inc. | A2a adenosine receptor antagonists |
US20070010522A1 (en) * | 2003-04-09 | 2007-01-11 | Chi Vu | Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists |
US7674791B2 (en) | 2003-04-09 | 2010-03-09 | Biogen Idec Ma Inc. | Triazolopyrazines and methods of making and using the same |
US7285550B2 (en) | 2003-04-09 | 2007-10-23 | Biogen Idec Ma Inc. | Triazolotriazines and pyrazolotriazines and methods of making and using the same |
TW200507850A (en) | 2003-07-25 | 2005-03-01 | Kyowa Hakko Kogyo Kk | Pharmaceutical composition |
WO2006129626A1 (ja) * | 2005-05-30 | 2006-12-07 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4]トリアゾロ[1,5-c]ピリミジン誘導体の製造法 |
ATE556712T1 (de) | 2005-06-07 | 2012-05-15 | Kyowa Hakko Kirin Co Ltd | A2a antagonisten zur behandlung von motorischen störungen |
US20090124663A1 (en) * | 2005-06-08 | 2009-05-14 | Neurosearch A/S | Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
TW200803856A (en) | 2005-09-02 | 2008-01-16 | Mount Cook Biosciences Inc | Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity |
ES2273599B1 (es) | 2005-10-14 | 2008-06-01 | Universidad De Barcelona | Compuestos para el tratamiento de la fibrilacion auricular. |
US7615556B2 (en) * | 2006-01-27 | 2009-11-10 | Bristol-Myers Squibb Company | Piperazinyl derivatives as modulators of chemokine receptor activity |
CN102014959B (zh) | 2008-03-10 | 2016-01-20 | 康奈尔大学 | 血脑屏障通透性的调节 |
WO2010008775A1 (en) * | 2008-06-23 | 2010-01-21 | Ligand Pharmaceuticals Inc. | Aminopyridopyrazinone derivatives for treating neurodegenerative diseases |
GB201214106D0 (en) * | 2012-08-07 | 2012-09-19 | Univ Strathclyde | Immunomodulatory compounds |
WO2017173067A1 (en) | 2016-03-31 | 2017-10-05 | Versi Group, Llc | Delta opioid agonist, mu opioid antagonist compositions and methods for treating parkinson's disease |
CN106866582A (zh) * | 2017-01-10 | 2017-06-20 | 广州隽沐生物科技有限公司 | 一种氟班色林中间体的制备方法 |
KR102633145B1 (ko) * | 2018-06-26 | 2024-02-05 | 쩌지앙 빔그린 파머슈티컬스, 엘티디 | A2a 수용체 길항제로서의 트리아졸로 트리아진 유도체 |
WO2020227156A1 (en) * | 2019-05-03 | 2020-11-12 | Nektar Therapeutics | Adenosine 2 receptor antagonists |
WO2022224180A1 (en) * | 2021-04-23 | 2022-10-27 | Chong Kun Dang Pharmaceutical Corp. | Compound as adenosine a2a receptor antagonist and pharmaceutical composition comprising same |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1264901B1 (it) | 1993-06-29 | 1996-10-17 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina |
US5565460A (en) | 1993-07-27 | 1996-10-15 | Kyowa Hakko Koygo Co., Ltd. | Therapeutic purine agents for parkinson's disease |
IT1277392B1 (it) | 1995-07-28 | 1997-11-10 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina |
EP0976753B1 (en) * | 1997-03-24 | 2004-01-02 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
IT1291372B1 (it) | 1997-05-21 | 1999-01-07 | Schering Plough S P A | Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie |
AU2639299A (en) | 1998-02-24 | 1999-09-15 | Kyowa Hakko Kogyo Co. Ltd. | Remedies/preventives for parkinson's disease |
DE69923197T2 (de) * | 1998-09-22 | 2005-12-29 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-DERIVATE |
US6355653B1 (en) | 1999-09-06 | 2002-03-12 | Hoffmann-La Roche Inc. | Amino-triazolopyridine derivatives |
JP2002037787A (ja) * | 2000-05-16 | 2002-02-06 | Kyowa Hakko Kogyo Co Ltd | [1,2,4]トリアゾロ[1,5−c]ピリミジン誘導体の製造法 |
BRPI0111015B8 (pt) | 2000-05-26 | 2021-05-25 | Merck Sharp & Dohme | composto antagonista de receptor a2a de adenosina, composição farmacêutica compreendendo o mesmo, seu uso e processos para a preparação de compostos intermediários |
US6653315B2 (en) * | 2001-10-15 | 2003-11-25 | Schering Corporation | Adenosine A2a receptor antagonists |
HUP0402324A3 (en) * | 2001-11-30 | 2008-09-29 | Schering Corp | [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine derivatives as adenosine a2a receptor antagonists and pharmaceutical compositions containing them |
-
2002
- 2002-11-26 HU HU0402324A patent/HUP0402324A3/hu unknown
- 2002-11-26 DE DE60219196T patent/DE60219196T2/de not_active Expired - Lifetime
- 2002-11-26 CN CNA028239679A patent/CN1688581A/zh active Pending
- 2002-11-26 AT AT02789893T patent/ATE358130T1/de not_active IP Right Cessation
- 2002-11-26 AU AU2002352933A patent/AU2002352933A1/en not_active Abandoned
- 2002-11-26 KR KR1020047007953A patent/KR20050044600A/ko not_active Application Discontinuation
- 2002-11-26 JP JP2003549353A patent/JP4429724B2/ja not_active Expired - Fee Related
- 2002-11-26 WO PCT/US2002/037915 patent/WO2003048163A1/en active IP Right Grant
- 2002-11-26 IL IL16157302A patent/IL161573A0/xx unknown
- 2002-11-26 ES ES02789893T patent/ES2283625T3/es not_active Expired - Lifetime
- 2002-11-26 EP EP02789893A patent/EP1453836B1/en not_active Expired - Lifetime
- 2002-11-26 US US10/304,939 patent/US6875772B2/en not_active Expired - Lifetime
- 2002-11-26 MX MXPA04005158A patent/MXPA04005158A/es active IP Right Grant
- 2002-11-26 CA CA002468658A patent/CA2468658C/en not_active Expired - Fee Related
- 2002-11-27 AR ARP020104562A patent/AR037681A1/es unknown
- 2002-11-27 TW TW091134487A patent/TW200300689A/zh unknown
- 2002-11-28 PE PE2002001149A patent/PE20030653A1/es not_active Application Discontinuation
-
2004
- 2004-05-27 ZA ZA200404168A patent/ZA200404168B/en unknown
- 2004-09-10 HK HK04106857A patent/HK1064097A1/xx not_active IP Right Cessation
- 2004-10-26 US US10/973,642 patent/US7078408B2/en not_active Expired - Lifetime
-
2009
- 2009-10-26 JP JP2009245977A patent/JP2010018634A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ZA200404168B (en) | 2005-09-02 |
HUP0402324A2 (hu) | 2005-02-28 |
JP2005511697A (ja) | 2005-04-28 |
US20050113380A1 (en) | 2005-05-26 |
MXPA04005158A (es) | 2004-08-11 |
EP1453836A1 (en) | 2004-09-08 |
AU2002352933A1 (en) | 2003-06-17 |
CA2468658A1 (en) | 2003-06-12 |
AR037681A1 (es) | 2004-12-01 |
WO2003048163A1 (en) | 2003-06-12 |
US7078408B2 (en) | 2006-07-18 |
EP1453836B1 (en) | 2007-03-28 |
CN1688581A (zh) | 2005-10-26 |
DE60219196D1 (de) | 2007-05-10 |
PE20030653A1 (es) | 2003-08-04 |
US6875772B2 (en) | 2005-04-05 |
US20030191130A1 (en) | 2003-10-09 |
CA2468658C (en) | 2009-04-14 |
KR20050044600A (ko) | 2005-05-12 |
TW200300689A (en) | 2003-06-16 |
ES2283625T3 (es) | 2007-11-01 |
HUP0402324A3 (en) | 2008-09-29 |
JP2010018634A (ja) | 2010-01-28 |
ATE358130T1 (de) | 2007-04-15 |
DE60219196T2 (de) | 2008-01-03 |
JP4429724B2 (ja) | 2010-03-10 |
HK1064097A1 (en) | 2005-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL161573A0 (en) | [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS | |
AU6808901A (en) | Adenosine a2a receptor antagonists | |
HK1063780A1 (en) | Adenosine a2a receptor antagonists | |
IL161572A0 (en) | Adenosine a2a receptor antagonists | |
HUP0401925A3 (en) | A2b adenosine receptor antagonists | |
IL160878A0 (en) | Imidazo (4,3-e)-1,2,4-triazolo (1,5-c) pyrimidines as adenosine a2a receptor antagonists | |
HUP0401437A3 (en) | Adenosine a3 receptor agonists | |
MXPA03004439A (es) | Aminotiazoles y su uso como antagonistas del receptor de adenosina. | |
IL147198A0 (en) | N-pyrazole a2a receptor agonists | |
IL147195A0 (en) | C-pyrazole a2a receptor agonists | |
MXPA03008967A (es) | Antagonistas receptores de 8-heteroarilo xantina adenosina a-2b. | |
TWI365879B (en) | A2b adenosine receptor antagonists | |
PL373953A1 (en) | 7-amino-benzothiazole derivatives as adenosine receptor ligands | |
SG80041A1 (en) | Muscarinic receptor antagonists | |
HK1049835A1 (en) | Selective antagonists of a2b adenosine receptors a2b. | |
HK1059927A1 (en) | Condensed purine derivatives as a1 adenosine receptor antagonists | |
HK1038919A1 (zh) | 作為速激肽受體拮抗劑的萘甲酰胺 | |
IL162444A0 (en) | Triazolo-quinolin derivatives useful as adenosine receptor ligands | |
PL370565A1 (en) | 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists | |
AU4980999A (en) | A3 adenosine receptor antagonists | |
EP1636230A4 (en) | ADENOSINE A1 RECEPTOR ANTAGONISTS | |
IL156087A0 (en) | Histamine receptor antagonists | |
IL158063A0 (en) | Crf receptor antagonists | |
SI1444233T1 (sl) | Antagonisti adenozinskega receptorja A2B | |
AU2002226519A1 (en) | Pyrrolo(2,3-d)pyrimidine and their use as purinergic receptor antagonists |